Both prolactin and progesterone in proestrus are necessary for the induction of apoptosis in the regressing corpus luteum of the rat

Biology of Reproduction

Volumn 59, Issue 5, 1998, Pages 1200-1206

  Gaytan F ^a   Bellido, C ^a   Morales, C ^a   Sanchez Criado J E ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; GONADORELIN[1 (N ACETYL 4 CHLORO DEXTRO PHENYLALANINE) 2 (4 CHLORO DEXTRO PHENYLALANINE) 3 DEXTRO TRYPTOPHAN 6 DEXTRO ARGININE 10 DEXTRO ALANINE]; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; ESTRUS CYCLE; FEMALE; HORMONAL REGULATION; LUTEOLYSIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROLACTIN RELEASE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOPTOSIS; BROMOCRIPTINE; CORPUS LUTEUM; DOPAMINE AGONISTS; FEMALE; GONANES; HORMONE ANTAGONISTS; LUTEOLYSIS; MACROPHAGES; MIFEPRISTONE; PROESTRUS; PROGESTERONE; PROLACTIN; RATS; RATS, WISTAR;

EID: 0031769965     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod59.5.1200     Document Type: Article

References (52)

1. Rothchild I. The regulation of the mammalian corpus luteum Recent Prog Horm Res 1981; 37:183-295.
2. Niswender GD, Nett TM. The corpus luteum and its control. In: Knobil E, Neill JD (eds.), The Physiology of Reproduction. New York: Raven Press; 1988: 489-526.
3. Niswender GD, Juengel JL, McGuire WJ, Belfiore CJ, Wiltbank MC. Luteal function: the estrous cycle and early pregnancy. Biol Reprod 1994; 50:239-247.
4. Paavola LG, Boyd CO. Surface morphology of macrophages in the regressing corpus luteum, as revealed by scanning electron microscopy. Anat Rec 1979; 195:659-682.
5. Kirsch TM, Vogel RL, Flickinger GL. Macrophages: a source of luteotropic cybernins. Endocrinology 1983; 113:1910-1912.
6. Bagavandoss P, Kunkel SL, Wiggins RC, Keyes PL. Tumor necrosis factor-α (TNF-α) production and localization of macrophages and T lymphocytes in the rabbit corpus luteum. Endocrinology 1988; 122: 1185-1187.
7. Bagavandoss P, Wiggins RC, Kunkel SL, Remick DG, Keyes PL. Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol Reprod 1990; 42:367-376.
8. Lei ZM, Chegini N, Rao ChV. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod 1991; 44:1148-1156.
9. 2α-induced luteolysis. Biol Reprod 1994; 50:10-15.
10. Townson TM, Warren JS, Flory CM, Naftalin DM, Keyes PL. Expression of monocyte chemoattractant protein-1 in the corpus luteum of the rat. Biol Reprod 1996; 54:513-520.
11. Bowen JM, Keyes PL, Warren JS, Townson DH. Prolactin-induced regression of the rat corpus luteum: expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol Reprod 1996; 54:1120-1127.
12. Gaytán F, Morales C, Bellido C, Aguilar E, Sánchez-Criado JE. Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing corpora lutea. Biol Reprod 1997; 57:478-486.
13. Naftalin DM, Bove SE, Keyes PL, Townson DH. Estrogen withdrawal induces macrophage invasion in the rabbit corpus luteum. Biol Reprod 1997; 55:1175-1180.
14. Rothchild I. The corpus luteum revisited: are the paradoxical effects of RU486 a clue to how progesterone stimulates its own secretion? Biol Reprod 1996; 55:1-4.
15. Rothchild I. Interrelations between progesterone and the ovary, pituitary, and central nervous system in the control of ovulation and the regulation of progesterone secretion. Vitam Horm 1965; 23:209-327.
16. Peluso JJ. Placing progesterone in the apoptotic pathway. Trends Endocrinol Metab 1997; 8:267-271.
17. Van der Schoot P, Bakker GH, Klijn JGM. Effects of the progesterone antagonist RU486 on ovarian activity in the rat. Endocrinology 1987; 121:1375-1382.
18. Ruiz A, Aguilar R, Tébar M, Gaytán F, Sánchez-Criado JE. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies. Biol Reprod 1996; 55:1284-1291.
19. Rotello R, Lieberman R, Lepoff R, Gerschenson L. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU486. Am J Pathol 1992; 140:449-456.
20. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 1995; 131:1095-1103.
21. Juengel JL, Garverick HA, Johnson AL, Yungquist RS, Smith MF. Apoptosis during luteal regression in cattle. Endocrinology 1993; 132: 249-254.
22. Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril 1988; 449:964-968.
23. Sugino N, Shimamura K, Tamura H, Ono M, Nakamura Y, Ogino K. Progesterone inhibits superoxide radical production by mononuclear phagocytes in pseudopregnant rats. Endocrinology 1996; 137:749-754.
24. Gaytán F, Morales C, Bellido C, Aguilar E, Sánchez-Criado JE. Proliferative activity in the different ovarian compartments in cycling rats estimated by the 5-bromodeoxyuridine technique. Biol Reprod 1996; 54:1356-1365.
25. Damoiseaux JGMC, Döp EA, Calame W, Chao D, MacPherson GG, Dijstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83:140-147.
26. Wyllie AH. What is apoptosis? Histopathology 1986; 10:995-998.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
28. Jolly PD, Smith PR, Heath DA, Hudson NL, Lun S, Still LA, Watts CH, McNatty KP. Morphological evidence of apoptosis and the prevalence of apoptosis versus mitotic cells in the membrana granulosa of ovarian follicles during spontaneous and induced atresia in ewes. Biol Reprod 1997; 56:837-846.
29. Young FM, Illingworth PJ, Lunn SF, Harrison DJ, Fraser HM. Cell death during luteal regression in the marmoset monkey (Callithrix jacchus). J Reprod Fertil 1997; 111:109-119.
30. 2α. Biol Reprod 1998; 58:169-174.
31. Shaw-Jenq T, Juengel JL, Wiltbank MC. Hormonal regulation of monocyte chemoattractant protein-1 messenger ribonucleic acid expression in corpora lutea. Endocrinology 1997; 138:4517-4520.
32. 2α receptor in ovine corpus luteum. Biol Reprod 1996; 54:1096-1102.
33. 2α. Domest Anim Endocrinol 1990; 7:229-238.
34. Matsuyama S, Chang KT, Yoshida S, Nishihara M, Takahashi M. Isolation of programmed cell death related genes from rat corpus luteum. Biol Reprod 1995; 52(suppl 1):67 (abstract 41).
35. Shikone T, Yamoto M, Kokawa K, Yamashita K, Nishimori K, Nakano R. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 1996; 81:2376-2380.
36. Wutke W, Meites J. Evidence for a luteolytic function of prolactin during the estrous cycle of the rat. Proc Soc Exp Biol Med 1971; 137: 988-991.
37. Uilenbroek JThJ. Hormone concentrations and ovulatory response in rats treated with antiprogestagens. J Endocrinol 1991; 129:423-429.
38. Sanchez Criado JE, Tebar M, Sánchez A, Gaytán F. Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats. J Reprod Fertil 1993; 99:173-179.
39. Uchida K, Kadowaki M, Miyake T. Ovarian secretion of progesterone and 20-α hydroxypregnen-4-en-3-one during rat estrous cycle in chronological relation to pituitary release of luteinizing hormone. Endocrinol Jpn 1969; 16:227-237.
40. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 1975; 96:219-226.
41. Horwitz K. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 1992; 13: 146-163.
42. Beck CA, Zhang Y, Weigel NL, Edwards DP. Two types of antiprogestins have distinct effects on site-specific phosphorylation of human progesterone receptor. J Biol Chem 1996; 271:1209-1217.
43. Ringstrom SJ, Szabo M, Kilen SM, Saberi S, Knox KL, Schwartz NB. The antiprogestins RU486 and ZK98299 affect follicle-stimulating hormone secretion differentially on estrus, but not on proestrus. Endocrinology 1997; 138:2286-2290.
44. Knox KL, Ringstrom SJ, Szabo M, Perlyn CA, Sutandi S, Schwartz NB. A RU486 on an estrogen background blocks the rise in serum follicle stimulating hormone induced by antiserum tu inhibin or ovariectomy. Endocrinology 1996; 137:1226-1232.
45. Levine JE. New concepts of the neuroendocrine regulation of gonadotropin surges in rats. Biol Reprod 1997; 56:293-302.
46. Schreiber JR, Hsueh AJW. Progesterone receptor in rat ovary. Endocrinology 1979; 105:915-919.
47. Schreiber JR, Nakamura K, Erickson GF. Rat ovary glucocorticoid receptor: identification and characterization. Steroids 1982; 35:569-584.
48. Neef G, Beier S, Elger W, Henderson D, Wiechert R. New steroids with antiprogestational and antiglucocorticoid activities. Steroids 1984; 44:349-372.
49. Elger W, Beier S, Chwalisz K, Fanrich M, Hasan SH, Henderson D, Neef G, Rohde R. Studies on the mechanisms of action of progesterone antagonists. J Steroid Biochem 1986; 22:835-845.
50. Kloosterboer HJ, Deckers GH, Schoonen WEGJ. Pharmacology of two new very selective antoprogestagens: Org31710 and Org31806. Hum Reprod 1994; 9(suppl 1):47-52.
51. Natraj U, Richards JS. Hormonal regulation, localization and functional activity of the progesterone receptors in granulosa cells of rat preovulatory follicles. Endocrinology 1993; 133:761-769.
52. Park OK, Mayo K. Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol Endocrinol 1991; 5:967-978.